GT
AGIO icon

Glenmede Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Glenmede Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-275
Closed -$9K – 1214
2020
Q3 		$9K Buy
275
+46
+20% +$2.02K ﹤0.01% 1903
2020
Q2 		$12K Sell
229
-147
-39% -$6.81K ﹤0.01% 1786
2020
Q1 		$17K Hold
376
– – ﹤0.01% 2167
2019
Q4 		$17K Buy
376
+349
+1,293% +$13.2K ﹤0.01% 2167
2019
Q3 		$0 Buy
+27
New +$1.12K ﹤0.01% 3000
2019
Q1 		– Sell
-245
Closed -$11 – 3046
2018
Q4 		$11 Buy
+245
New +$15.1K ﹤0.01% 2221
2018
Q3 		– Sell
-780
Closed -$66K – 1433
2018
Q2 		$66K Buy
+780
New +$68K ﹤0.01% 1363
2015
Q2 		– Sell
-763
Closed -$71K – 2675
2015
Q1 		$71K Buy
+763
New +$85.5K ﹤0.01% 1567

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return